Total Payments
$2,405
2024 Payments
$527.45
Companies
18
Transactions
118
Medicare Patients
331
Medicare Billing
$60,298
Payment Breakdown by Category
Food & Beverage$2,405 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,405 | 118 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,106 | 66 | $0 (2024) |
| Alkermes, Inc. | $183.56 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $159.43 | 4 | $0 (2023) |
| Bausch Health US, LLC | $144.89 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $133.06 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $99.86 | 1 | $0 (2021) |
| ITI, Inc. | $98.88 | 5 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $65.23 | 2 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $63.81 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $61.71 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.45 | 26 | ABBVIE INC. ($220.87) |
| 2023 | $718.52 | 36 | ABBVIE INC. ($262.30) |
| 2022 | $547.71 | 31 | ABBVIE INC. ($259.85) |
| 2021 | $611.25 | 25 | AbbVie Inc. ($363.10) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: CNS | ||||||
| 11/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: OUD | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Opioid Use Disorder | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Neurology | ||||||
| 06/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: OUD | ||||||
| 06/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: CNS | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Neuroscience | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 140 | 377 | $76,925 | $23,772 |
| 2022 | 4 | 129 | 316 | $64,960 | $22,232 |
| 2021 | 3 | 62 | 174 | $42,450 | $14,295 |
Total Patients
331
Total Services
867
Medicare Billing
$60,298
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 192 | $48,000 | $14,884 | 31.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 46 | 120 | $18,000 | $5,495 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 35 | $6,125 | $2,183 | 35.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 20 | 30 | $4,800 | $1,209 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 150 | $37,500 | $12,479 | 33.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 26 | 92 | $13,800 | $4,358 | 31.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 38 | 61 | $9,760 | $3,734 | 38.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 13 | 13 | $3,900 | $1,660 | 42.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 76 | $19,000 | $6,924 | 36.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 25 | 25 | $12,500 | $3,837 | 30.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 18 | 73 | $10,950 | $3,534 | 32.3% |
About Jessica Schmidt, PMHNP
Jessica Schmidt, PMHNP is a Addiction (Substance Use Disorder) healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2012. The National Provider Identifier (NPI) number assigned to this provider is 1205181005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Schmidt, PMHNP has received a total of $2,405 in payments from pharmaceutical and medical device companies, with $527.45 received in 2024. These payments were reported across 118 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,405).
As a Medicare-enrolled provider, Schmidt has provided services to 331 Medicare beneficiaries, totaling 867 services with total Medicare billing of $60,298. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction (Substance Use Disorder)
- Other Specialties Student in an Organized Health Care Education/Training Program, Psychiatric/Mental Health
- Location Santa Rosa, CA
- Active Since 07/17/2012
- Last Updated 11/05/2020
- Taxonomy Code 163WA0400X
- Entity Type Individual
- NPI Number 1205181005
Products in Payments
- VRAYLAR (Drug) $1,036
- INGREZZA (Drug) $159.43
- APLENZIN (Drug) $144.89
- ARISTADA (Drug) $140.37
- SPRAVATO (Drug) $133.06
- CAPLYTA (Drug) $128.16
- Epclusa (Drug) $99.86
- VIIBRYD (Drug) $69.80
- FANAPT (Drug) $65.23
- REXULTI (Drug) $61.71
- SUBLOCADE (Drug) $60.71
- Auvelity (Drug) $43.63
- ABILIFY MAINTENA (Drug) $42.17
- Qelbree (Drug) $39.93
- LATUDA (Drug) $29.74
- AUSTEDO (Drug) $24.21
- QELBREE (Drug) $23.88
- VIVITROL (Drug) $23.77
- Austedo XR (Drug) $20.95
- Azstarys (Drug) $20.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction (Substance Use Disorder) Doctors in Santa Rosa
Patricia O'connell, Ph.d, PH.D
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Deborah Pope
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Tom Newell
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Claudia Zbinden
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Michael Walsh
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Vince Helper
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)